埃洛图祖马布与波马利多米德,博尔特佐米布和德克萨米松联合使用,用于复发性和耐火性多发性骨髓瘤

Andrew J Yee1,2, Jacob P Laubach3,2, Erica L Campagnaro4

  • 1Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA.

Blood advances
|December 3, 2024
PubMed
概括

将埃洛图祖马布添加到波马利多米德,博尔特佐米布和德克萨米他 (elo-PVd) 中,对复发性/耐药性多发性骨髓瘤 (MM) 显示出有希望. 这种四重治疗方案在重度预治疗的患者中实现了56.3%的整体应答率.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K